Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter

Cancer Research

Volumn 57, Issue 18, 1997, Pages 3993-3999

  He, Yukai ^a   Huang, Leaf ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE;

ANIMAL CELL; ARTICLE; GENE EXPRESSION; GENE THERAPY; GROWTH INHIBITION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS INHIBITION; RNA SPLICING; RNA TRANSCRIPTION; TUMOR GROWTH; VIROGENESIS; WART VIRUS;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MICE; NEOPLASMS, EXPERIMENTAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROMOTER REGIONS (GENETICS); RNA, ANTISENSE; RNA, MESSENGER; RNA, VIRAL; TUMOR VIRUS INFECTIONS; VIRUS REPLICATION;

EID: 0030766214     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., and Shah, K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer. Inst. (Bethesda), 87: 796-802, 1995.
2. zur Hausen, H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. In: H. zur Hausen (ed.), Human Pathogenic Papillomavirus, pp. 131-156. Berlin: Springer-Verlag, 1994.
3. Tan, T. M. C. and Ting, R. C. Y. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Cancer Res., 55: 4599-4905, 1995.
4. Steele, C., Cowsert, L. M., and Shillitoe, E. J. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines. Cancer Res., 53: 2330-2337, 1993.
5. Steele, C., Sacks, P. G., Adler-Storthz, K., and Shillitoe, E. J. Effect on cancer cells of plasmids that express antisense RNA of human papillomavirus type 18. Cancer Res., 52: 4706-4711, 1992.
6. Watanabe, S., Kanda, T., and Yoshiike, K. Growth dependence of human papillomavirus 16 DNA-positive cervical cancer cell lines and human papillomavirus 16-transformed human and rat cells on the viral oncoproteins. Jpn. J. Cancer Res., 84: 1043-1049, 1993.
7. Hamada, K., Sakaue, M., Alemany, R., Zhang, W-W., Horio, Y., Roth, J. A., and Mitchell, M. F. Adenovirus-mediated transfer of HPV16 E6/E7 antisense RNA to human cervical cancer cells. Gynecol. Oncol., 60: 373-379, 1996.
8. Chen, Z., Kamath, P., Zhang, S., Weil, M. M., and Shillitoe, E. J. Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18. Cancer Gene Ther., 3: 18-23, 1996.
9. Scherczinger, C. A., Yates, A. A., and Knecht, D. A. Variables affecting antisense RNA inhibition of gene expression. Ann. N.Y. Acad. Sci., 660: 45-56, 1992.
10. Denhardt, D. T. Mechanism of action of antisense RNA. Ann. N.Y. Acad. Sci., 660: 70-76, 1992.
11. Bradley, M. O., Manam, S., Kraynak, A. R., Nichols, W. W., and Ledwith, B. Reversal of transformed phenotypes by antisense fos. Ann. N.Y. Acad. Sci., 660: 124-135, 1992.
12. Schillitoe, E. J., and Steele, C. Inhibition of the transformed phenotype of carcinoma cells that contain human papillomavirus. Ann. N.Y. Acad. Sci., 660: 286-287, 1992.
13. Graeven, U., Rodeck, U., Weinmann, R., and Herlyn, M. Stable transfection of human malignant melanoma cells with basic fibroblast growth factor antisense cDNA. Ann. N.Y. Acad. Sci., 660: 293-294, 1992.
14. Noonberg, S. B., Scott, G. K., Garovoy, M. R., Benz, C. C., and Hunt, C. A. In vivo generation of highly abundant sequence specific oligonucleolides for antisense and triplex gene regulation. Nucleic Acids Res., 22: 2830-2836, 1994.
15. Kunkel, G. R. RNA polymerase III transcription of genes that lack internal control regions. Biochim. Biophys. Acta, 1088: 1-9, 1991.
16. Feltkamp, M. C. W., Smits, H. L., Vierboom, M. P. M., Minnaar, R. P., de Jongh, B. M., Drijfhout, J. W., ter Schegget, J., Melief, C. J. M., and Kast, W. M. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol., 23: 2242-2249, 1993.
17. Sato, H., Furuno, A., and Yoshike, K. Expression of human papillomavirus type 16 E7 gene induces DNA synthesis of rat 3Y1 cells. Virology, 168: 195-199, 1989.
18. Gao, X., and Huang, L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun., 179: 280-285, 1991.
19. Son, K., and Huang, L. Factors influencing the drug sensitization of human tumor cells for in situ lipofection. Gene Ther., 3: 630-634, 1996.
20. Hofland, H., and Huang, L. Inhibition of human ovarian carcinoma cell proliferation by liposome/plasmid DNA complex. Biochem. Biophys. Res. Commun., 207: 492-496,1995.
21. Crooke, S. T. Therapeutic applications of oligonucleotides. Annu. Rev. Pharmacol. Toxicol., 32: 329-376, 1992.
22. Thompson, J. D., Ayers, D. F., Malmstrom, T. A., Mckenzie, T. L., Ganousis, L., Chowrira, B. M., Couture, L., and Stinchcomb, D. T. Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter. Nucleic Acids Res., 23: 2259-2268, 1995.
23. Kunkel, G. R., and Pederson, T. Transcription of a human U6 small nuclear RNA gene in vivo withstands deletion of intragenic sequences but not of an upstream TATATA box. Nucleic Acids Res., 17: 7371-7379, 1989.
24. Das, G., Henning, D., Wright, D., and Reddy, R. Upstream regulatory elements are necessary and sufficient for transcription of a U6 RNA gene by RNA polymerase III. EMBO J., 7: 503-512, 1988.
25. Good, P. D., Krikos, A. J., Li, S. X. L., Bertrand, E., Lee, N. S., Giver, L., Ellington, A., Zaia, J. A., Rossi, J. J., and Engelke, D. R. Expression of small, therapeutic RNAs in human cell nuclei. Gene Ther., 4: 45-54, 1997.
26. Ohta, Y., Kijima, H., Ohkawa, T., Mohammed, K-S., and Scanlon, K. J. Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells. Nucleic Acids Res., 24: 938-942, 1996.
27. von Knebel Doeberitz, M., Rittmuller, C., zur Hausen, H., and Durst, M. Inhibition of tumorigenicity of C4-1 cervical cancer cells in nude mice by HPV18 E6-E7 antisense RNA. Int. J. Cancer, 51: 831-834, 1992.
28. Sedman, S. A., Barbosa, M. S., Vass, W. C. Hubbert, N. L., Haas, J. A., Lowy, D. R., and Shiller, J. T. The full-length E6 protein of human papillomavirus type 16 has transforming and transactivating activities and cooperates with E7 to immortalize kertinocytes in culture. J. Virol., 65: 4860-4866, 1991.
29. Tahara, H., and Lotze, M. T. Antitumor effects of interleukin-12 (IL-12): application for the immunotherapy and gene therapy of cancer. Gene Ther., 2: 96-106, 1995.